MON-187 The E23K Missense Variant of the Gene Encoding the Pancreatic Beta-Cell KATP Channel Subunit Kir6.2 (KCNJ11) Associates with Diabetic Retinopathy and Hyperglycemia Control in Type 2 Diabetes Patients

2019

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1210/js.2019-mon-187
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

BACKGROUND. The ATP-sensitive K (KATP) channel regulates insulin sensitivity, by linking insulin secretion to changes in blood glucose levels. HYPOTHESIS. Kir6.2 is a specific point mutation in KCNJ11 gene, which encodes the pore-forming subunit of the pancreatic KATP channel, and was reportedly linked with impaired insulin secretion and diabetes development. METHODOLOGY. We investigated whether the E23K Kir6.2 polymorphism is associated with the presence of diabetic retinopathy (DR) in 804 Tunisian type 2 diabetes (T2DM) patients. Genotype analysis was performed by real-time PCR. MAJOR RESULTS. While the E23K minor allele frequency was comparable between T2DM patients with (DR) and without (DWR) retinopathy (32.3% vs. 31.9%; P = 0.919), the distribution of E23K genotypes was significantly different between both T2DM patient groups (P = 0.024). In T2DM patients with HbA1c values < 7.0%, the T/T genotype was present at higher frequency in DR (14.9%) than in DWR (4.3%) patients (P = 0.007). Regression analysis confirmed the association of Kir6.2 K/K genotype with DR in patients with normal HbA1c (P = 0.022; OR = 12.70; 95% CI = 1.46-10.25). CONCLUSIONS. The E23K Kir6.2 polymorphism is associated with DR in T2DM in an HbA1c-dependent manner, thereby suggesting that Kir6.2 E23K homozygosity may predict the extent of hyperglycemic control in DR patients.